GSK plc (GSK)
NYSE: GSK · Real-Time Price · USD
33.60
+0.17 (0.51%)
Dec 20, 2024, 4:00 PM EST - Market closed
GSK Employees
GSK plc had 70,212 employees as of December 31, 2023. The number of employees increased by 812 or 1.17% compared to the previous year.
Employees
70,212
Change (1Y)
812
Growth (1Y)
1.17%
Revenue / Employee
$597,707
Profits / Employee
$47,933
Market Cap
67.72B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 70,212 | 812 | 1.17% |
Dec 31, 2022 | 69,400 | -20,696 | -22.97% |
Dec 31, 2021 | 90,096 | -3,970 | -4.22% |
Dec 31, 2020 | 94,066 | -5,371 | -5.40% |
Dec 31, 2019 | 99,437 | 3,947 | 4.13% |
Dec 31, 2018 | 95,490 | -2,972 | -3.02% |
Dec 31, 2017 | 98,462 | -838 | -0.84% |
Dec 31, 2016 | 99,300 | -1,955 | -1.93% |
Dec 31, 2015 | 101,255 | 3,334 | 3.40% |
Dec 31, 2014 | 97,921 | -1,530 | -1.54% |
Dec 31, 2013 | 99,451 | -37 | -0.04% |
Dec 31, 2012 | 99,488 | 2,099 | 2.16% |
Dec 31, 2011 | 97,389 | 928 | 0.96% |
Dec 31, 2010 | 96,461 | -3,452 | -3.46% |
Dec 31, 2009 | 99,913 | 910 | 0.92% |
Dec 31, 2008 | 99,003 | -4,480 | -4.33% |
Dec 31, 2007 | 103,483 | 788 | 0.77% |
Dec 31, 2006 | 102,695 | 1,967 | 1.95% |
Dec 31, 2005 | 100,728 | 709 | 0.71% |
Dec 31, 2004 | 100,019 | -900 | -0.89% |
Dec 31, 2003 | 100,919 | -3,580 | -3.43% |
Dec 31, 2002 | 104,499 | -2,971 | -2.76% |
Dec 31, 2001 | 107,470 | -47 | -0.04% |
Dec 31, 2000 | 107,517 | -1,524 | -1.40% |
Dec 31, 1999 | 109,041 | -7,780 | -6.66% |
Dec 31, 1998 | 116,821 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
HCA Healthcare | 310,000 |
CVS Health | 300,000 |
Becton, Dickinson and Company | 73,000 |
The Cigna Group | 72,500 |
McKesson | 51,000 |
Cencora | 46,000 |
Haleon | 25,408 |
Edwards Lifesciences | 19,800 |
GSK News
- 2 days ago - GSK's cancer drugs meet progression-free survival goal in late-stage trial - Reuters
- 11 days ago - Relation announces two strategic collaborations with GSK to advance therapeutics for fibrotic diseases and osteoarthritis - GlobeNewsWire
- 12 days ago - GSK's drug combo shown to cut risk of death by 42% in type of blood cancer - Reuters
- 17 days ago - GSK, China's Zhifei Expand Shingles Shot Collaboration - WSJ
- 17 days ago - GSK expands deal with China's Zhifei to explore RSV vaccine collaboration - Reuters
- 4 weeks ago - GSK's RSV vaccine gets Japan approval for adults aged 50 to 59 - Reuters
- 4 weeks ago - GSK share price is imploding: is it safe to buy the dip? - Invezz
- 4 weeks ago - GSK drug meets main goal in late-stage study to treat relentless itch - Reuters